Skip to main content

and
  1. Article

    Open Access

    Altered DNA methylation in estrogen-responsive repetitive sequences of spermatozoa of infertile men with shortened anogenital distance

    It has been suggested that antenatal exposure to environmental endocrine disruptors is responsible for adverse trends in male reproductive health, including male infertility, impaired semen quality, cryptorchi...

    Ludwig Stenz, Matthias Beyens, Mark E. Gill in Clinical Epigenetics (2022)

  2. No Access

    Article

    Insufficient evidence for a role of SERPINF1 in otosclerosis

    Otosclerosis is a common form of hearing loss (HL) due to abnormal remodeling of the otic capsule. The genetic causes of otosclerosis remain largely unidentified. Only mutations in a single gene, SERPINF1, were p...

    Hanne Valgaeren, Manou Sommen, Matthias Beyens in Molecular Genetics and Genomics (2019)

  3. Article

    Open Access

    Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer

    Breast cancer is the most frequent cancer among women worldwide. Biomarkers for early detection and prognosis of these patients are needed. We hypothesized that deafness, autosomal dominant 5 (DFNA5) may be a val...

    Lieselot Croes, Matthias Beyens, Erik Fransen, Joe Ibrahim in Clinical Epigenetics (2018)

  4. Article

    Open Access

    pyAmpli: an amplicon-based variant filter pipeline for targeted resequencing data

    Haloplex targeted resequencing is a popular method to analyze both germline and somatic variants in gene panels. However, involved wet-lab procedures may introduce false positives that need to be considered in...

    Matthias Beyens, Nele Boeckx, Guy Van Camp, Ken Op de Beeck in BMC Bioinformatics (2017)

  5. Article

    Open Access

    Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors

    The mTOR-inhibitor everolimus improves progression-free survival in advanced pancreatic neuroendocrine tumours (PNETs). However, adaptive resistance to mTOR inhibition is described.

    Timon Vandamme, Matthias Beyens, Ken Op de Beeck, Fadime Dogan in British Journal of Cancer (2016)